Latest news
Stephenson Global Scholar Grants Award $6.7 Million to Accelerate Pancreatic Cancer Breakthroughs - Business WireBusiness Wire · Mon, 10 Aug 2026 16:17:00 GMTAIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:53 GMTNew drug delivers promising survival gains in pancreatic cancer - News-MedicalNews-Medical · Mon, 10 Aug 2026 03:11:00 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago TribuneChicago Tribune · Sun, 09 Aug 2026 11:00:17 GMT'We're excited and ready to go': Fast-growing Revolution Medicines preps potential launch of blockbuster pancreatic cancer drug - The Business JournalsThe Business Journals · Fri, 07 Aug 2026 13:29:00 GMT$2 Million NCI Grant Funds Research on How Pancreatic Cancer Uses Cholesterol to Survive - The University of OklahomaThe University of Oklahoma · Thu, 06 Aug 2026 20:46:15 GMTBreakthrough Drug Brings Hope to Utah Grandfather with Pancreatic Cancer - University of Utah HealthUniversity of Utah Health · Thu, 06 Aug 2026 15:00:00 GMTTango hopes it takes two: vopimetostat combos build on Revolution's pancreatic cancer breakthrough - FirstWord PharmaFirstWord Pharma · Thu, 06 Aug 2026 14:48:37 GMT